In our approach, we analyse tumour cells immediately after resection by flow cytometry and have also observed high levels of CD133 expression on colon cancer tumour specimens subjected to mass spectrometry-based proteomics (Van Orden et al, 2007). The gene discussed is PROM1; the disease is malignant colon neoplasm.